• Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World
Newsy Today
news of today
Home - Viruses
Tag:

Viruses

Health

Early Release – Serologic Surveillance of Highly Pathogenic Avian Influenza Virus Subtype H5 in Wildlife, Northeast Germany, 2023–2025 – Volume 32, Number 5—May 2026 – Emerging Infectious Diseases journal

by Chief Editor April 28, 2026
written by Chief Editor

The Growing Threat of H5 Avian Influenza in Mammals

The landscape of avian influenza has shifted. What were once seasonal outbreaks have evolved into a perpetual presence in Europe, creating a global panzootic that threatens not only domestic and wild birds but an increasing variety of mammals. From terrestrial predators to marine species, the “spillover” of highly pathogenic avian influenza viruses (HPAIV) subtype H5 is no longer a rare occurrence—it is a systemic risk. Although much of the public focus remains on poultry, the interface between birds and mammals is where the most concerning evolutionary leaps occur. Recent data indicates that mammalian infections often stem from direct, alimentary exposure—essentially, mammals eating infected birds. In predatory and scavenging species, this has led to severe neurological symptoms and encephalitis, often resulting in death.

Did you understand? While many infections are fatal, some studies suggest a level of asymptomatic infection, meaning some mammals can survive exposure to HPAIV H5 without showing immediate signs of illness.

Why Carnivores are on the Front Line

Not all mammals are equally at risk. Research conducted in northeast Germany, specifically in the state of Mecklenburg–Western Pomerania, highlights a stark contrast in susceptibility between different animal groups. In a study of hunted game, wild ruminants (herbivores) showed no seropositivity against the virus. In contrast, carnivorous species—including foxes, raccoons, and raccoon dogs—showed significant levels of H5-specific antibodies, with seropositivity rates ranging from 12.5% to 21.9%.

The Role of Geography and Habitat

The risk of infection isn’t just about *what* the animal is, but *where* it lives. For red foxes, the environment plays a critical role in viral exposure:

  • Water Access: Foxes located near the Baltic Sea, bay coasts, or watercourses (such as streams, rivers, and canals) face a significantly higher risk of testing positive for H5 antibodies.
  • Habitat Buffers: Interestingly, a high proportion of shrubland within a 2.5-km buffer zone appears to act as a protective factor, likely by reducing exposure to water-associated hosts like Anseriformes (waterfowl).
  • The Age Factor: Exposure increases over time. In studied fox populations, adult foxes showed a seropositivity rate of 23.5%, compared to 11.6% in juveniles.

For more on how environmental factors influence disease spread, explore our guide on One Health and Ecosystem Management.

The “Mixing Vessel” Risk: Wild Boars and Viral Evolution

Event-Based Surveillance for Early Detection of Emerging Threats

One of the most critical findings for future pandemic preparedness is the role of the wild boar (Sus scrofa). While not primary predators, wild boars are omnivores and known “nest robbers” of waterfowl in wetland areas. Recent surveillance found that 3.5% of wild boars in specific water-associated zones were seropositive for H5. While this percentage is lower than that of carnivores, the implications are far more serious. Suidae species are considered “mixing vessels”—animals that can be infected by swine-, human-, and avian-derived influenza viruses simultaneously. When different virus strains inhabit the same host, they can swap genetic material. This process could potentially lead to the emergence of a new strain that is more easily transmissible among mammals or humans.

Pro Tip for Wildlife Observers: If you encounter dead wildlife in wetland areas, avoid direct contact. Report sightings to local veterinary or environmental authorities to help maintain critical surveillance data.

Future Outlook: From Wildlife to Our Doorsteps

The transition of HPAIV H5 into a perpetual enzootic state means that the risk of spillover is constant. The focus of surveillance is now expanding beyond wild game to include “bridge” animals—pets that move between wild habitats and human households. Free-ranging cats and hunting dogs are primary candidates for this bridge. A dog returning from a hunt or a cat stalking birds in a backyard can bring the virus from a wetland hotspot directly into a home. The future of preventing a mammalian pandemic relies on an “Integrated One Health” approach. This means combining the expertise of veterinarians, environmental scientists, and human physicians to monitor the interface where humans, animals, and the environment meet.

Learn more about the One Health approach to understand how multidisciplinary research prevents the next outbreak.

Frequently Asked Questions

What is a “spillover event” in the context of H5?

A spillover event occurs when a virus that typically circulates in one species (in this case, wild birds) jumps to a different species (such as a fox, boar, or human).

Frequently Asked Questions
Carnivores Avian Influenza

Why are wild boars called “mixing vessels”?

Wild boars can be susceptible to multiple types of influenza viruses (avian, swine, and human). This allows different strains to mix and potentially mutate into new, more dangerous variants.

Are all mammals at risk of H5 avian influenza?

While many species are susceptible, the risk varies. Carnivores and omnivores that eat birds or live in wetlands are at much higher risk than herbivores like deer.

How does the environment affect the spread of H5?

Proximity to water is a major driver. Animals living near coasts, rivers, or marshes have more frequent contact with reservoir hosts like waterfowl, increasing their chance of infection.


Join the Conversation: Do you think current wildlife surveillance is enough to protect public health? Share your thoughts in the comments below or subscribe to our newsletter for the latest updates on zoonotic disease research.

April 28, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Maryland reports 2 more measles tied to Baltimore-area residents

by Chief Editor April 25, 2026
written by Chief Editor

The Resurgence of Preventable Diseases: Understanding the Current Trends

Public health officials are seeing a worrying pattern as preventable diseases, such as measles, reappear in communities. While high overall vaccination rates provide a strong shield, recent data indicates that “pockets” of lower immunity are creating vulnerabilities. In Maryland, for example, health officials recently confirmed two additional cases among Baltimore-area residents, bringing the state’s total for the year to three.

View this post on Instagram about Maryland, Public
From Instagram — related to Maryland, Public

These cases highlight a broader national trend, with close to 1,800 reported infections across multiple states this year. The resurgence isn’t random; it is closely tied to shifts in travel patterns and the spread of health-related misinformation.

Did you understand? Measles is incredibly contagious because it spreads through the air. An infected person’s cough or sneeze can leave the virus lingering in a space for up to two hours after they have already left the area.

The Role of Travel in Modern Outbreaks

In an interconnected world, a local outbreak is often the result of global or interstate movement. The most recent cases in Maryland were specifically linked to residents who had traveled to other states where measles transmission was already active.

This trend suggests that public health monitoring must extend beyond local borders. When individuals travel from areas with high transmission to regions with “immunity gaps,” the risk of a localized outbreak increases significantly, regardless of the state’s general health standing.

Confronting the Misinformation Crisis

One of the most significant challenges facing modern medicine is the rise of vaccine misinformation and disinformation. While Maryland has maintained a high vaccination rate—with more than 96% of kindergartners receiving two doses before the last school year—rates have begun to tick down in specific pockets.

These small drops in coverage can be dangerous. When vaccination rates fall below a certain threshold in a specific neighborhood or community, “herd immunity” weakens, allowing a single imported case to spark a wider outbreak. This makes targeted community outreach and the dissemination of evidence-based facts more critical than ever.

Pro Tip: If you suspect you have been exposed to measles, do not go directly to a doctor’s office or emergency room. Contact your healthcare provider first to prevent potentially exposing other patients in the waiting room.

Protecting the Community: The Science of Prevention

The primary defense against these outbreaks remains the measles-mumps-rubella (MMR) vaccine, which experts describe as highly effective. Maintaining high vaccination levels is the only way to ensure that those who cannot be vaccinated for medical reasons remain protected.

Two more cases of measles confirmed in Maryland

For those unsure of their status, reviewing medical records or consulting a physician is the first step. Access to these vaccines is widely available; they are covered by insurance, and those who are uninsured or underinsured can access them through the Vaccines for Children Program or via a local health department.

Recognizing the Signs and Taking Action

Early detection is key to stopping the spread. Symptoms typically appear one to three weeks after exposure and include:

Recognizing the Signs and Taking Action
Public Maryland
  • High fever
  • Running nose
  • Cough
  • A telltale red body rash that spreads from head to toe

Because individuals are contagious four days before and four days after the rash develops, isolation is mandatory. Those exposed are advised to stay home from work and school for three weeks to prevent further community transmission.

Public health departments are now utilizing highly detailed exposure lists—including specific times and locations like grocery stores, cafes, and professional buildings—to identify and notify at-risk individuals quickly. You can learn more about public health safety measures to stay protected.

Frequently Asked Questions

How does measles spread?

It is an airborne virus spread through coughing or sneezing. It can remain active in the air for up to two hours after an infected person leaves the room.

What should I do if I’ve been exposed?

Monitor for symptoms for one to three weeks. If you are exposed, you should stay home from work or school for three weeks and call your doctor before visiting a clinic.

Is the MMR vaccine effective?

Yes, experts state that the measles-mumps-rubella vaccine is highly effective at preventing the disease.

Where can I receive a vaccine if I don’t have insurance?

Uninsured or underinsured individuals can obtain vaccines through the Vaccines for Children Program or their local health department.


Stay Informed: Have you checked your vaccination records recently? Protecting yourself helps protect your entire community. Share this article with your neighbors or leave a comment below to discuss how your community is handling public health awareness.

April 25, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

CDC detects new COVID-19 variant across 25 US states via wastewater samples

by Chief Editor March 25, 2026
written by Chief Editor

New COVID Variant BA.3.2 Spreading: What You Demand to Know

A new variant of COVID-19 is circulating in the U.S. And globally, prompting health officials to monitor its spread and characteristics. The SARS-CoV-2 BA.3.2 variant has been reported in at least 23 countries as of February 11, according to a recent study by the Centers for Disease Control and Prevention (CDC).

Understanding the BA.3.2 Variant

The BA.3.2 variant is genetically distinct from previous strains like JN.1, LP.8.1, and XFG that dominated infections since January 2024. It possesses approximately 70 to 75 changes in its spike protein – the part of the virus that allows it to enter human cells. This significant number of mutations is a key factor driving concern among researchers.

First confirmed in the U.S. In June 2025, after being detected in a traveler arriving from the Netherlands, BA.3.2 began to rise in prevalence starting in September 2025. From November 2025 to January 2026, weekly detections reached around 30% of cases in Denmark, Germany, and the Netherlands.

Immune Escape and Potential Impact

The CDC has identified “immune escape characteristics” in BA.3.2. This means the mutations in the variant may allow it to partially evade immunity gained from prior COVID-19 infections or vaccinations. While this could lead to more infections, experts currently believe it doesn’t necessarily translate to more severe illness.

The CDC’s advisory panel recently shifted COVID vaccine guidance toward “individual decision-making,” encouraging patients to discuss vaccination with their doctors. This approach keeps shots covered under major insurance programs.

Detection and Surveillance

As of the CDC’s Morbidity and Mortality Weekly Report, BA.3.2 has been detected in the U.S. Through various surveillance methods: nasal swabs from four travelers, clinical samples from five patients, three airplane wastewater samples, and 132 wastewater surveillance samples collected from 25 states.

Researchers emphasize the importance of ongoing genomic surveillance to track the virus’s evolution and assess its potential impact on public health. The prevalence of BA.3.2 may be underestimated due to limited genomic detection and surveillance capabilities in many countries.

Ongoing Viral Evolution

Two sublineages of BA.3.2, BA.3.2.1 and BA.3.2.2, have been identified, indicating continued viral evolution. This highlights the virus’s ability to adapt and change over time.

Frequently Asked Questions

Q: Does the BA.3.2 variant cause more severe illness?
Currently, there is no evidence to suggest that BA.3.2 causes more severe illness than previous variants, but ongoing monitoring is crucial.

Q: Are existing COVID-19 vaccines effective against BA.3.2?
The variant’s immune escape characteristics suggest vaccines may be less effective at preventing infection, but they still offer protection against severe illness.

Q: What can I do to protect myself?
Staying up-to-date with vaccinations, practicing good hygiene (handwashing), and considering masking in crowded indoor spaces are recommended preventative measures.

Q: Where can I find more information about COVID-19 variants?
Visit the Fox News Coronavirus section or the CDC website for the latest updates.

Pro Tip: Wastewater surveillance is a valuable tool for tracking the spread of COVID-19 and identifying new variants, even in areas with limited individual testing.

Stay informed and consult with your healthcare provider for personalized advice on protecting yourself and your family.

Explore more health news on Fox News.

March 25, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Seaweed Fucoidan Could Block Norovirus Infection

by Chief Editor March 18, 2026
written by Chief Editor

Seaweed’s Surprising Potential: A Natural Shield Against Norovirus?

For millions worldwide, norovirus – often called the “winter vomiting bug” – is an unwelcome guest, causing widespread outbreaks of gastroenteritis. With over 685 million infections reported annually and no approved vaccines or antiviral treatments currently available, the search for effective prevention strategies has been ongoing. Now, groundbreaking research suggests a surprising ally in this fight: seaweed.

How Seaweed Could Block Infection

Collaborative research between Griffith University in Australia and biotechnology company Marinova has revealed that compounds found in certain seaweeds may act as a physical barrier against norovirus infection. The key lies in how noroviruses infect the body. They attach to molecules in the intestine called histo-blood group antigens (HBGAs).

Researchers tested two seaweed compounds, fucoidan and ulvan, to determine their ability to prevent norovirus from binding to human saliva samples containing HBGAs. Fucoidan, derived from brown seaweed, demonstrated the most promising results, consistently blocking activity against two major norovirus strains: GII.4 and GII.17. The fucoidan appears to bind to the HBGA binding pocket, essentially creating a shield that makes it harder for the virus to attach and infect cells.

Fucoidan: A Familiar Compound with New Promise

Fucoidan isn’t a new discovery. It has a history of use in dietary supplements and has shown good tolerability in human studies. Associate Professor Thomas Haselhorst, a co-senior author of the study, highlighted that this existing safety profile is a significant advantage. “Our study highlights that fucoidan could be a promising, natural treatment for preventing norovirus infection,” he stated.

Did you know? Norovirus is highly contagious and a leading cause of gastroenteritis, characterized by symptoms like nausea, vomiting, diarrhea, fever, stomach pain, headache and muscle aches.

Future Directions: Formulating for Maximum Impact

Even as the initial findings are encouraging, researchers are now focused on optimizing how fucoidan can be formulated to maximize its protective effect within the gastrointestinal tract. This includes exploring different delivery methods and dosages to ensure optimal efficacy.

Beyond Prevention: A Potential Boost for Vaccine Development

The research doesn’t just offer a potential preventative measure; it could also inform the development of future vaccines. A related study, highlighted by BioTechniques, focuses on creating a system to better understand how norovirus genes function, potentially opening new avenues for antiviral development and vaccine creation.

The Rise of Marine-Derived Pharmaceuticals

This research is part of a growing trend of exploring marine environments for pharmaceutical solutions. Seaweed, in particular, is attracting attention due to its rich source of bioactive compounds with potential health benefits. The relatively untapped biodiversity of the ocean represents a vast resource for discovering novel treatments for a range of diseases.

Pro Tip:

While fucoidan shows promise, it’s important to remember that this research is ongoing. Consult with a healthcare professional before making any significant changes to your diet or supplement regimen.

Frequently Asked Questions

Q: What is norovirus?
A: Norovirus is a highly contagious virus that causes gastroenteritis, leading to vomiting and diarrhea.

Q: Is there a vaccine for norovirus?
A: Currently, there are no approved vaccines for norovirus.

Q: What is fucoidan?
A: Fucoidan is a compound found in brown seaweed that has shown potential in blocking norovirus infection.

Q: Is fucoidan safe?
A: Fucoidan has a history of dietary use and has demonstrated good tolerability in human studies.

Q: Where can I find fucoidan supplements?
A: Fucoidan is available in some premium dietary supplements. Always consult with a healthcare professional before starting any new supplement.

Want to learn more about the latest breakthroughs in health and wellness? Subscribe to our newsletter for regular updates and expert insights.

March 18, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Bird Flu: Black Vultures Hit Hard – New Study & Mutation Risk

by Chief Editor March 18, 2026
written by Chief Editor

Black Vulture Die-Off Signals Wider Bird Flu Threat

A concerning new study from the University of Georgia reveals that black vultures are being decimated by highly pathogenic avian influenza (H5N1), commonly known as bird flu. More than 84% of 134 deceased black vultures examined across seven Southeastern states tested positive for the virus in 2022 and 2023, raising alarms about the potential for increased mutation and spread to other species.

A Year-Round Cycle of Disease

Unlike typical bird flu seasons, black vultures’ scavenging habits appear to be sustaining the virus year-round. Researchers observed vultures consuming the carcasses of infected birds, creating a dangerous feedback loop. “Every day, more carcasses would appear, and we could notice that the black vultures were eating their dead cohorts,” explained Dr. Nicole Nemeth, lead author of the study and head of UGA’s Southeastern Cooperative Wildlife Disease Study. “From a survival perspective, that’s smart. It’s a ready-made, available food source. But it perpetuates this cycle of disease within the vulture population year-round.”

Mutation Concerns and the Human Risk

The sustained transmission of H5N1 is particularly worrisome as it increases the opportunities for the virus to mutate. While there is currently no evidence of the virus jumping to humans via the vulture population, the potential remains a significant concern. “This virus is scary. It’s changing. And it’s doing continual damage to our wildlife—on top of all the other challenges these wildlife already face,” Nemeth stated.

Ecological Impact Beyond Vultures

Black vultures play a crucial ecological role by removing carcasses that could spread disease. A decline in vulture populations could lead to an increase in disease transmission to other animals and even humans. “In areas where vulture populations have been diminished, there are a lot more dead animals left in the landscape, which actually has been shown to contribute to increased diseases in people, wildlife, and domestic animals,” Nemeth noted.

Vulnerability Across Species

While black vultures are relatively abundant, the study highlights the vulnerability of other bird species with smaller populations. A 2023 outbreak of bird flu among California condors, for example, resulted in the deaths of at least 20 birds – a devastating loss for a species with fewer than 600 individuals remaining.

Resilience and Future Outlook

Despite the high mortality rate, research suggests that approximately half of the black vultures exposed to avian influenza survive, developing antibodies that may offer some protection against future outbreaks. This indicates a degree of resilience within the population. However, researchers emphasize the ongoing diversity of avian influenza viruses and the potential for new, more virulent strains to emerge.

“Avian influenza is incredibly diverse. These highly pathogenic viruses continue to circulate and mix up, and it’s creating a huge potential diversity of different viruses, many of which wildlife species in North America may not have seen before,” said Rebecca Poulson, a coauthor of the study.

Bird Flu’s Expanding Host Range

Originally detected in the 1990s, H5N1 has periodically caused outbreaks in wild and domesticated birds. More recently, the virus has been detected in a wider range of animals, including dairy cows, house cats, dolphins, and bears, raising concerns about its potential for broader transmission.

Frequently Asked Questions

  • What is avian influenza (bird flu)? Avian influenza is a highly contagious viral disease that affects birds, and can sometimes spread to other animals.
  • Are humans at risk from this outbreak? Currently, there is no evidence of the virus spreading to humans from the vulture population, but the potential for mutation remains a concern.
  • Why are black vultures particularly affected? Their scavenging behavior leads to frequent exposure to the virus, creating a year-round cycle of transmission.
  • What is being done to monitor the situation? Researchers at the University of Georgia are continuing to monitor the spread of the virus in wildlife populations.

Pro Tip: Reporting any unusual bird deaths to your local wildlife authorities can facilitate track the spread of avian influenza and protect vulnerable species.

Learn more about avian influenza and its impact on wildlife by visiting the University of Georgia News website.

March 18, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

130 Children Exposed at Education Center

by Chief Editor March 9, 2026
written by Chief Editor

Measles Cases Rise in Sacramento Region: A Growing Concern

Sacramento County public health officials are responding to a potential measles outbreak after more than 100 children were possibly exposed at an educational enrichment program. The incident highlights a concerning trend of increasing measles cases, not only locally but across the state and nation.

Exposure and Current Cases

The recent exposure occurred when an unvaccinated child who was infectious attended the program in Sacramento County. Health officials are currently tracing contacts, with as many as 130 children potentially affected. As of March 6, at least six cases of measles have been confirmed in Sacramento and neighboring Placer County. One of the infected children received treatment at Kaiser Permanente Roseville Medical Center, prompting a contact tracing effort among patients and staff who were present on March 2.

The Danger of Measles

Dr. Erica Pan, CDPH Director and State Public Health Officer, emphasized the severity of measles, stating it is “one of the most contagious infections” and can lead to “severe life-long consequences including permanent brain damage and can also be fatal, especially for children.” The highly contagious nature of the virus means it can remain suspended in the air for up to two hours in a room, even without direct contact with an infected person.

Link to South Carolina Outbreak

At least one case in Placer County has been linked to travel to South Carolina, where a large outbreak has already been confirmed with over 1,100 cases. This underscores the risk of importing measles from areas experiencing outbreaks.

Vaccination: The Best Defense

Public health officials are strongly urging individuals to check their immunization status and get vaccinated with the measles-mumps-rubella (MMR) vaccine. The MMR vaccine is considered safe and provides long-lasting protection against measles. Vaccination not only protects individuals but also contributes to community immunity, safeguarding those too young to be vaccinated or with compromised immune systems.

What to Expect if Infected

Symptoms of measles can initially resemble a cold. After one to three weeks, a splotchy rash typically develops on the face and spreads down the body. Individuals can be infectious up to four days before symptoms appear, making early detection and isolation crucial.

Frequently Asked Questions

What are the symptoms of measles?

Symptoms include fever, cough, runny nose, and a rash that typically appears on the face and spreads downward.

How can I protect myself and my family?

The most effective way to protect yourself and your family is to get vaccinated with the MMR vaccine.

What should I do if I think I’ve been exposed to measles?

Contact your healthcare provider immediately and inform them of your potential exposure.

Pro Tip: Maintain your vaccination records readily available for quick reference. If you’re unsure of your vaccination status, contact your healthcare provider.

Learn more about measles and vaccination from the California Department of Public Health.

Have questions about the recent measles cases? Share your thoughts in the comments below!

March 9, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Early Release – Tuberculosis after TB Preventive Therapy in Persons Living with HIV Recently Initiating Antiretroviral Therapy, Mozambique – Volume 32, Number 3—March 2026 – Emerging Infectious Diseases journal

by Chief Editor February 26, 2026
written by Chief Editor

Mozambique’s Fight Against Tuberculosis: Progress, Challenges, and Future Strategies

Tuberculosis (TB) remains a significant public health threat, particularly for individuals living with HIV. In Mozambique, substantial progress has been made in expanding TB preventive therapy (TPT) among people newly initiating antiretroviral therapy (ART), reaching 89% coverage by March 2024. However, recent data reveals persistent challenges and highlights the need for targeted interventions to further reduce TB incidence.

The Impact of TPT: A National Success Story

Since 2007, Mozambique has prioritized TPT as a key strategy to combat TB among people living with HIV. The introduction of a 3-month course of isoniazid and rifapentine (3HP) in 2023, alongside the traditional 6-month isoniazid regimen, has further bolstered these efforts. A recent analysis of national data from 2021-2022 demonstrates a clear link between TPT completion and reduced TB incidence. Individuals who completed TPT experienced a significantly lower rate of TB diagnosis compared to those who did not start or incompletely finished the therapy.

Specifically, the incidence of diagnosed TB was 3.1 per 1,000 person-years among those who completed TPT, compared to 21.6 per 1,000 person-years for those who didn’t start TPT and 11.0 per 1,000 person-years for those with incomplete TPT. This underscores the critical role of ensuring patients adhere to and complete their TPT regimens.

Uneven Progress: Identifying Vulnerable Populations

Despite the overall success of TPT programs, certain populations remain disproportionately affected by TB. The data reveals higher TB incidence rates among men, younger individuals (<15 years), older individuals (>50 years), and those with poorer clinical status at the start of ART – including unsuppressed viral loads, low CD4 counts, and advanced WHO clinical staging (stages II-IV). Individuals in the Southern Region of Mozambique also exhibited elevated TB rates, potentially linked to regional variations in TB services and case detection.

Pro Tip: Targeted interventions focusing on these vulnerable groups are crucial for maximizing the impact of TPT programs. This includes tailored outreach, adherence support, and addressing underlying health factors.

The Future of TPT: Exploring New Approaches

While TPT has proven effective, ongoing research is exploring potential refinements to the strategy. The question of whether a second course of TPT would provide additional benefit for those who complete an initial regimen remains a subject of debate. A recent randomized controlled trial in Ethiopia, Mozambique, and South Africa did not demonstrate a significant advantage from a repeat course of 3HP. However, further investigation may be warranted for specific high-risk individuals.

Enhancing data quality and leveraging national data warehouses, like Mozambique’s MozART system, are also essential for monitoring program effectiveness and identifying areas for improvement. Continued investment in surveillance, testing, and outbreak preparedness, in collaboration with organizations like the CDC and USAID, will be vital for sustaining progress.

Strengthening Health Systems for Long-Term Impact

The success of Mozambique’s TB control efforts is inextricably linked to the strength of its overall health system. Support for the National Tuberculosis Control Program (PNCT) and the National Institute of Health (INS) network of TB reference laboratories, as well as training for public health professionals, are critical components of a sustainable response. Strengthening electronic health and laboratory information systems will further enhance data-driven decision-making and improve patient care.

Did you know? Mozambique closed its wild poliovirus outbreak in 2024, demonstrating the power of collaborative public health initiatives.

Frequently Asked Questions

Q: What is TPT?
A: TPT stands for TB preventive therapy. It’s a medication regimen given to people with HIV to prevent them from developing active TB disease.

Q: Why is TPT important for people with HIV?
A: People living with HIV are significantly more likely to develop TB. TPT reduces this risk and can save lives.

Q: What are the challenges to TPT implementation?
A: Challenges include ensuring patients start and complete the full course of therapy, reaching vulnerable populations, and maintaining data quality.

Q: What is MozART?
A: MozART is Mozambique’s national ART data warehouse, containing clinical data from over 1.6 million people living with HIV.

This ongoing commitment to collaboration, data-driven strategies, and targeted interventions will be essential for achieving epidemic control of TB and protecting the health of the Mozambican population.

February 26, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Viral Infection Linked to ALS: New Mouse Model Offers Hope for Treatment

by Chief Editor February 7, 2026
written by Chief Editor

ALS and Viral Infections: A Potential Turning Point in Understanding Motor Neuron Disease

Researchers at Texas A&M University have made a significant discovery linking viral infections to the development of amyotrophic lateral sclerosis (ALS), a devastating motor neuron disease. This breakthrough centers around a specific mouse strain, CC023, which exhibits ALS-like symptoms following a viral infection, offering a new avenue for research and potential treatments.

The CC023 Strain: A New Model for ALS Research

For years, scientists have theorized that viruses could play a role in triggering neurological diseases like ALS, even long after the initial infection has cleared. The identification of the CC023 mouse strain provides the first animal model to validate this theory. “This is exciting since this is the first animal model that affirms the long-standing theory that a virus can trigger permanent neurological damage or disease—like ALS—long after the infection itself occurred,” explains Candice Brinkmeyer-Langford, a neurogenerative disease expert at Texas A&M.

How the Study Unfolded: TMEV and Spinal Cord Inflammation

The research team utilized Theiler’s murine encephalomyelitis virus (TMEV) to infect five different strains of mice, carefully monitoring their responses throughout the acute, subacute, and chronic phases of infection. Key areas of investigation included spinal cord inflammation, levels of inflammation across strains, the correlation between inflammation and paralysis, and the amount of virus present.

Four key findings emerged from the study:

  • Early Nerve Damage: Nerve damage was observed in the lumbar spine of all mouse strains within the first two weeks of infection, with some showing signs as early as four days post-infection.
  • Persistent Muscle Loss: The CC023 mice experienced permanent muscle wasting even after the virus was eliminated from their spinal cords.
  • ALS-Like Symptoms: The CC023 strain developed physical symptoms and lesions remarkably similar to those seen in human ALS patients.
  • Immune Response Dynamics: An initial strong immune response to the virus subsided once the virus was cleared, but the damage remained.

Genetics and Susceptibility: Why Some Are More Vulnerable

The study underscores the importance of genetic predisposition in the development of ALS following a viral infection. The CC023 strain’s unique response highlights that certain individuals may be more susceptible to lasting neurological damage after a viral encounter. “The bottom line… is that genetics matter,” Brinkmeyer-Langford stated.

Implications for Sporadic ALS and Future Treatments

This research is particularly relevant to sporadic ALS, the most common form of the disease, accounting for over 90% of cases and not linked to hereditary factors. The CC023 strain offers a “test track” for identifying biomarkers that appear after infection, potentially leading to earlier diagnosis and the development of targeted therapies. The ability to study the lasting effects of viral infection in this model could unlock new strategies for preventing or slowing the progression of ALS.

Frequently Asked Questions

Q: What is ALS?
A: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to muscle weakness, paralysis, and eventually death.

Q: What role do viruses play in ALS?
A: This research suggests that viral infections may trigger lasting neurological damage and contribute to the development of ALS in genetically susceptible individuals.

Q: What is the CC023 mouse strain?
A: CC023 is a specific type of mouse that develops ALS-like symptoms after being infected with a virus, making it a valuable model for studying the disease.

Q: Is ALS hereditary?
A: While some cases of ALS are hereditary, the majority (over 90%) are sporadic, meaning they do not have a clear genetic cause.

Pro Tip

Early detection is crucial for managing ALS. If you experience unexplained muscle weakness, twitching, or difficulty with speech or swallowing, consult a neurologist immediately.

Source: Texas A&M University

Want to learn more about neurological diseases? Explore our other articles on brain health and neurodegenerative conditions. Click here to browse our neurology section.

February 7, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Early Release – Integrating Prevention and Response at the Crossroads of Henipavirus Preparedness, Hendra@30 Conference, 2024 – Volume 32, Number 1—January 2026 – Emerging Infectious Diseases journal

by Chief Editor January 22, 2026
written by Chief Editor

The Looming Threat of Henipaviruses: A New Era of Preparedness

The world is bracing for the next pandemic, and increasingly, the spotlight is falling on a family of viruses known as henipaviruses. Recent scientific gatherings, like the Hendra@30 conference, reveal a rapidly evolving understanding of these deadly pathogens – Hendra virus (HeV) and Nipah virus (NiV) – and a growing number of related viruses lurking in bat populations. This isn’t just an academic exercise; it’s a critical race against time to develop defenses against potential outbreaks with devastating consequences.

Decoding the Viral Landscape: Expanding Diversity

For years, HeV and NiV were the primary concerns. Now, metagenomic sequencing is uncovering a vast, previously hidden diversity of henipaviruses in bats, particularly flying foxes. The Hendra@30 conference highlighted the discovery of 24 new henipavirus species in Australian bats alone. This expanded viral landscape dramatically increases the potential for spillover events. While many of these newly identified viruses haven’t been isolated, their genetic presence signals a heightened risk. The sheer number of undiscovered viruses underscores the need for proactive surveillance and research.

Did you know? The discovery of new henipaviruses isn’t necessarily a cause for immediate panic. However, it emphasizes the importance of understanding the factors that drive viral evolution and spillover.

The Ecological Tightrope: Habitat Loss and Spillover Risk

The link between environmental change and henipavirus spillover is becoming increasingly clear. Research presented at Hendra@30 demonstrates that habitat loss is forcing flying foxes to alter their behavior, increasingly seeking food in close proximity to human and animal populations. Specifically, the loss of natural flowering resources drives bats to rely on readily available, but less nutritious, food sources like date palm sap – a known vector for NiV transmission in Bangladesh. This creates a perfect storm for viral transmission.

In Australia, studies show that HeV spillovers are more frequent when flying foxes are forced to congregate near horse populations due to dwindling natural food sources. Strategic habitat restoration, providing consistent access to natural foraging resources, is emerging as a potentially sustainable countermeasure. This approach focuses on supporting bat health and minimizing contact with susceptible hosts.

Medical Countermeasures: Progress and Bottlenecks

The development of medical countermeasures – diagnostics, therapeutics, and vaccines – remains a top priority. While several small molecule drugs and nanobodies are in preclinical development, progress is hampered by a lack of robust clinical data. A systematic review identified key bottlenecks: well-designed clinical efficacy trials and in vivo pharmacokinetic studies. The WHO’s updated Nipah R&D roadmap aims to accelerate this process, but securing sustainable funding remains a significant challenge.

Pro Tip: The focus is shifting towards proactive vaccine development for priority pathogens, as championed by the Coalition for Epidemic Preparedness and Innovations (CEPI). This “100-day mission” aims to rapidly deploy vaccines against emerging threats.

The Power of Collaboration: A Global Approach

The Hendra@30 conference underscored the importance of international collaboration. Delegations from all countries affected by henipaviruses were present, representing 66% of attendees. The organizing committee prioritized inclusivity, with 74% female representation and over a third early-career scientists. Travel grants were provided to emerging scholars from low- and middle-income countries, fostering a more equitable research landscape.

The newly established Paramyxovirus Collaborative Open Research Consortium (CORC), co-hosted by WHO and the Indian Council of Medical Research, aims to further strengthen global collaboration and knowledge sharing. However, concerns remain regarding its operationalization, funding, and decision-making processes.

Immunity Insights: A Deeper Dive

Understanding the immune response to henipaviruses is crucial for vaccine development. Recent research is focusing on both cell-mediated immunity (CMI) and innate immunity. Studies are exploring how the virus interacts with the immune system, and how to harness this knowledge to develop more effective vaccines. Future conferences are expected to dedicate more attention to this critical area, particularly examining the immune responses of survivors in affected regions.

The Future of Henipavirus Research: Key Areas to Watch

Several emerging areas of research hold significant promise:

  • Ex vivo models: Organoids and organs-on-a-chip are providing more realistic models for studying viral replication and pathogenesis.
  • Viral genetics: Continued genomic surveillance is essential for tracking viral evolution and identifying potential threats.
  • Bat ecology: Further research is needed to understand the complex interplay between bat behavior, habitat, and viral transmission.
  • Regulatory engagement: Involving national regulatory agencies in the research process will be crucial for accelerating the development and deployment of medical countermeasures.

FAQ: Henipaviruses – Your Questions Answered

  • What is the fatality rate of Nipah virus? The case fatality rate of Nipah virus can be as high as 80%.
  • How are henipaviruses transmitted to humans? Transmission typically occurs through contact with infected bats, pigs, or contaminated food (like date palm sap).
  • Is there a vaccine for Hendra or Nipah virus? Currently, there are no commercially available vaccines, but several are in development.
  • What can I do to protect myself? Avoid contact with bats and pigs in affected areas. Practice good hygiene and avoid consuming raw date palm sap.

The threat posed by henipaviruses is real and evolving. A proactive, collaborative, and ecologically informed approach is essential to mitigate the risk of future outbreaks and protect global health. Continued investment in research, surveillance, and preparedness is not just a scientific imperative – it’s a moral one.

What are your thoughts on the henipavirus threat? Share your comments below and explore our other articles on emerging infectious diseases. Subscribe to our newsletter for the latest updates and insights.

January 22, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Health experts scramble to contain outbreak of deadly Nipah virus

by Chief Editor January 21, 2026
written by Chief Editor

Nipah Virus: A Looming Threat and the Future of Emerging Disease Surveillance

India’s recent alert regarding Nipah virus, following new cases in West Bengal, isn’t an isolated incident. It’s a stark reminder of the increasing frequency and complexity of emerging infectious diseases. The virus, originating in bats, highlights a critical challenge: the blurring lines between animal and human health, and the urgent need for proactive, sophisticated surveillance systems.

The Rise of Zoonotic Diseases: A Global Trend

Nipah is a zoonotic disease – meaning it jumps from animals to humans. These diseases represent a growing proportion of new infections globally. According to the World Health Organization, around 60% of known infectious diseases and 75% of emerging infectious diseases are zoonotic. Factors driving this rise include deforestation, climate change, and increased human-animal interaction.

Consider the recent outbreaks of avian influenza (bird flu) impacting poultry and, increasingly, mammals. Or the ongoing concerns surrounding monkeypox, which saw a significant global surge in 2022. These events demonstrate a pattern: previously contained viruses are finding new pathways to spill over into human populations.

Beyond Nipah: The Challenge of Acute Encephalitis Syndrome (AES)

The focus on AES as a key indicator for potential Nipah infections is a crucial strategy. AES, a broad term for brain inflammation, can be caused by various pathogens, making accurate diagnosis challenging. Misidentification, as acknowledged by health officials in West Bengal, can lead to delayed responses and increased risk of human-to-human transmission, particularly within healthcare settings.

Pro Tip: Early and accurate diagnosis is paramount. Healthcare providers should maintain a high index of suspicion for Nipah in patients presenting with AES, especially those with a history of travel to or contact with affected areas.

The Role of Advanced Diagnostics and Genomic Sequencing

Traditional diagnostic methods often struggle to keep pace with rapidly evolving viruses. The future of disease surveillance lies in advanced diagnostics, including real-time PCR and, increasingly, genomic sequencing. Genomic sequencing allows scientists to track viral mutations, identify the source of outbreaks, and develop targeted interventions.

For example, during the Ebola outbreak in West Africa (2014-2016), genomic sequencing played a vital role in understanding the virus’s transmission patterns and developing a vaccine. Similar approaches are now being applied to Nipah and other emerging threats.

Strengthening Global Health Security: A One Health Approach

Addressing zoonotic diseases requires a “One Health” approach – a collaborative, multidisciplinary strategy that integrates human, animal, and environmental health. This means closer collaboration between public health agencies, veterinary services, and environmental organizations.

Investing in robust surveillance systems in animal populations is equally critical. Monitoring bat populations, for instance, can provide early warning signs of Nipah virus activity. Furthermore, addressing the underlying drivers of zoonotic spillover – such as deforestation and wildlife trade – is essential for long-term prevention.

The Impact of Climate Change on Disease Emergence

Climate change is exacerbating the risk of emerging infectious diseases. Altered weather patterns can disrupt ecosystems, forcing animals to migrate and increasing contact with humans. Rising temperatures can also expand the geographic range of disease vectors, such as mosquitoes and ticks.

A study published in Nature Climate Change found that climate change has already increased the suitability of regions for several vector-borne diseases, including dengue fever and malaria.

Future Trends in Nipah Virus Research

Current research focuses on developing effective treatments and vaccines for Nipah virus. Monoclonal antibody therapies are showing promise in clinical trials, and several vaccine candidates are under development. However, challenges remain, including the need for rapid scalability and affordability.

Did you know? There is currently no licensed vaccine or specific treatment for Nipah virus infection.

FAQ: Nipah Virus and Emerging Disease Threats

  • What is the fatality rate of Nipah virus? Up to 75%, making it a particularly dangerous pathogen.
  • How is Nipah virus transmitted? Through contaminated food, contact with infected animal fluids, or person-to-person via droplets and saliva.
  • What is Acute Encephalitis Syndrome (AES)? A broad term for brain inflammation that can be caused by various infections, including Nipah virus.
  • What is the “One Health” approach? A collaborative strategy integrating human, animal, and environmental health to address zoonotic diseases.
  • Is climate change increasing the risk of emerging diseases? Yes, by disrupting ecosystems and expanding the range of disease vectors.

The emergence of Nipah virus serves as a critical wake-up call. Investing in proactive surveillance, advanced diagnostics, and a One Health approach is not merely a matter of public health preparedness; it’s a necessity for safeguarding global health security in an increasingly interconnected and changing world.

Want to learn more? Explore our articles on Global Health Crises and Preventive Healthcare. Share your thoughts in the comments below!

January 21, 2026 0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts

Recent Posts

  • Assessing Nanjing Leads Biolabs (SEHK:9887) Valuation After Recent Share Price Volatility

    May 14, 2026
  • Setbacks continue for Suriya’s Karuppu release as noon shows get cancelled

    May 14, 2026
  • Nick Kurtz Hits 3rd Career Grand Slam in Athletics Win Over Cardinals

    May 14, 2026
  • Mental Health Crisis and Access Center marks over1 year, serving 1,000+

    May 14, 2026
  • Xi Jinping and Trump’s Historic Summit: Key Takeaways on U.S.-China Relations and Economic Cooperation

    May 14, 2026

Popular Posts

  • 1

    Maya Jama flaunts her taut midriff in a white crop top and denim jeans during holiday as she shares New York pub crawl story

    April 5, 2025
  • 2

    Saar-Unternehmen hoffen auf tiefgreifende Reformen

    March 26, 2025
  • 3

    Marta Daddato: vita e racconti tra YouTube e podcast

    April 7, 2025
  • 4

    Unlocking Success: Why the FPÖ Could Outperform Projections and Transform Austria’s Political Landscape

    April 26, 2025
  • 5

    Mecimapro Apologizes for DAY6 Concert Chaos: Understanding the Controversy

    May 6, 2025

Follow Me

Follow Me
  • Cookie Policy
  • CORRECTIONS POLICY
  • PRIVACY POLICY
  • TERMS OF SERVICE

Hosted by Byohosting – Most Recommended Web Hosting – for complains, abuse, advertising contact: o f f i c e @byohosting.com


Back To Top
Newsy Today
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World